which also brought in the encapsulation technology used in VX-264. Since then, the company has expanded its type 1 diabetes cell therapy platform with the $320 million takeover of rival developer ...
Along with VX-880, it is also working on encapsulated islet cells as a treatment for T1D, although that programme remains in preclinical development. Encapsulation could mean doing away with the ...
The µEncapsulator System from Dolomite Bio enables simple, quick and reliable encapsulation of single cells, DNA and/or functionalized beads in high precision, monodisperse picoliter droplets. The ...
Medical Xpress on MSN8d
Viral protein Nef enables a step toward off-the-shelf CAR T cell therapy for cancerCAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...
Julien Grogg, PhD, MBA - CEO of Release Therapeutics Release Tx logo Dr. Julien Grogg will Lead the Company's Transition to Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback